USBC, Inc. (USBC)
NYSEAMERICAN: USBC · Real-Time Price · USD
1.060
-0.040 (-3.64%)
Oct 8, 2025, 4:00 PM EDT - Market closed
Company Description
USBC, Inc., together with its subsidiaries, focuses on the development and commercialization of sensor technology by radio and microwave spectroscopy in the United States.
The company is involved in identifying and measuring material or analyte using electromagnetic energy to detect, record, identify, and measure the signature of materials or analytes.
The company was formerly known as Know Labs, Inc. and changed its name to USBC, Inc. in August 2025.
USBC, Inc. was incorporated in 1998 and is based in Reno, Nevada.
USBC, Inc.
Country | United States |
Founded | 1998 |
Industry | Scientific & Technical Instruments |
Sector | Technology |
Employees | 12 |
CEO | Robert Kidd |
Contact Details
Address: 300 E 2nd Street, 15th Floor Reno, Nevada 89501 United States | |
Phone | 775-239-7673 |
Website | usbc.xyz |
Stock Details
Ticker Symbol | USBC |
Exchange | NYSEAMERICAN |
Fiscal Year | October - September |
Reporting Currency | USD |
CIK Code | 0001074828 |
CUSIP Number | 499238103 |
ISIN Number | US4992382022 |
Employer ID | 90-0273142 |
SIC Code | 6199 |
Key Executives
Name | Position |
---|---|
Robert Gregory Kidd | Chief Executive Officer and Chairman |
Ronald P. Erickson J.D. | Founder, President of the Science Div., Senior Vice President and Lead Director |
Kitty B. Payne CPA | Chief Financial Officer, Secretary and Treasurer |
Kirk Chapman | Chief Operating Officer |
Dr. James H. Anderson Jr., M.D. | Chief Medical Officer and Chairman of Medical, Scientific and Regulatory Advisory Board |
Jordyn Hujar | Chief of Staff |
Dr. Dominic Klyve Ph.D. | Chief Science Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Oct 3, 2025 | 8-K | Current Report |
Sep 23, 2025 | SCHEDULE 13D/A | Filing |
Sep 19, 2025 | S-1 | General form for registration of securities under the Securities Act of 1933 |
Sep 5, 2025 | 424B5 | Filing |
Sep 5, 2025 | 8-K | Current Report |
Aug 26, 2025 | ARS | Filing |
Aug 26, 2025 | DEF 14A | Other definitive proxy statements |
Aug 21, 2025 | D | Notice of Exempt Offering of Securities |
Aug 15, 2025 | 8-K | Current Report |
Aug 13, 2025 | SCHEDULE 13D | Filing |